ADC Therapeutics Ltd (ADCT)
US Market

ADC Therapeutics (ADCT) Stock Price & Analysis


ADCT Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.68 - $5.75
Previous Close$0.82
Average Volume (3M)476.13K
Market Cap
Enterprise Value$42.97M
Total Cash (Recent Filing)$31.15M
Total Debt (Recent Filing)$7.66M
Price to Earnings (P/E)-0.4
Nov 16, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.26
Shares Outstanding80,642,530
10 Day Avg. Volume251,608
30 Day Avg. Volume476,125
Standard Deviation0.19
Financial Highlights & Ratios
Price to Book (P/B)-0.75
Price to Sales (P/S)0.32
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.31
Enterprise Value/Gross Profit0.21
Enterprise Value/Ebitda-0.42
Price Target Upside519.01% Upside
Rating ConsensusHold
Number of Analyst Covering5



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was ADC Therapeutics Ltd’s price range in the past 12 months?
ADC Therapeutics Ltd lowest stock price was $0.68 and its highest was $5.75 in the past 12 months.
    What is ADC Therapeutics Ltd’s market cap?
    Currently, no data Available
    When is ADC Therapeutics Ltd’s upcoming earnings report date?
    ADC Therapeutics Ltd’s upcoming earnings report date is Nov 16, 2023 which is in 43 days.
      How were ADC Therapeutics Ltd’s earnings last quarter?
      ADC Therapeutics Ltd released its earnings results on Aug 08, 2023. The company reported -$0.58 earnings per share for the quarter, beating the consensus estimate of -$0.7 by $0.12.
        Is ADC Therapeutics Ltd overvalued?
        According to Wall Street analysts ADC Therapeutics Ltd’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does ADC Therapeutics Ltd pay dividends?
          ADC Therapeutics Ltd does not currently pay dividends.
          What is ADC Therapeutics Ltd’s EPS estimate?
          ADC Therapeutics Ltd’s EPS estimate is -$0.61.
            How many shares outstanding does ADC Therapeutics Ltd have?
            ADC Therapeutics Ltd has 80,642,525 shares outstanding.
              What happened to ADC Therapeutics Ltd’s price movement after its last earnings report?
              ADC Therapeutics Ltd reported an EPS of -$0.58 in its last earnings report, beating expectations of -$0.7. Following the earnings report the stock price went up 11.888%.
                Which hedge fund is a major shareholder of ADC Therapeutics Ltd?
                Among the largest hedge funds holding ADC Therapeutics Ltd’s share is Perceptive Advisors LLC. It holds ADC Therapeutics Ltd’s shares valued at N/A.


                  ADC Therapeutics Stock Smart Score

                  The ADC Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  ADC Therapeutics Ltd

                  ADC Therapeutics SA is a United States-based clinical-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ADCT-402, ADCT-301, ADCT-602, and ADCT-601.


                  Top 5 ETFs holding ADCT

                  Currently, no data available
                  Please return soon. This page is being updated.
                  Up to five ETFs with an Outperform Smart Score that hold ADCT. The ETFs are listed according to market value of ADCT within the ETF

                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Adverum Biotechnologies
                  Adaptimmune Therapeutics
                  Adaptive Biotechnologies

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis